Rigel Pharmaceuticals Inc. logo

Rigel Pharmaceuticals Inc.

RIGL | NASDAQ
Chart Builder DCF Calculator
$47.09
+$0.45 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$47.09
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$862.94M
Enterprise Value
$815.88M
Beta
1.20
Average Volume
368.34K
Shares Outstanding (Diluted)
19.57M
Shares Change YoY
7.75%
Institutional Ownership
86.92%
Exchange
NASDAQ
ISIN
US7665597024

Price Performance

Price Change 1M
2.4%
Price Change 3M
32.2%
Price Change 6M
79.1%
Price Change YTD
12.6%
Price Change 1Y
36.7%
Price Change 3Y
332.0%
Price Change 5Y
25.9%
1M CAGR (ann.)
18.9%
1Y CAGR (ann.)
36.3%
5Y CAGR (ann.)
3.8%
All-Time CAGR
-4.2%

Valuation

PE Ratio
2.89
Forward PE
8.81
PEG Ratio
0.01
Forward PEG
0.08
PS Ratio
3.15
Forward PS
2.30
PB Ratio
2.05
P/FCF Ratio
10.61
P/Adj. FCF Ratio
14.00
P/OCF Ratio
11.00
EV/Sales
2.95
EV/EBIT
8.93
EV/EBITDA
8.76
EV/FCF
9.94
Earnings Yield
34.7%
FCF Yield
9.4%
Adj. FCF Yield
7.1%

Financial Health

Net Cash
$56.09M
Total Debt
$39.95M
Cash & Short-Term Investments
$95.33M
Total Assets
$521.07M
Current Ratio
1.95
Quick Ratio
1.79
Debt / Equity Ratio
0.09
Debt / EBITDA
0.43
Debt / FCF
0.49
OCF / Debt
2.06
Interest Coverage
15.00
Altman Z-Score
4.06
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
91.4%
Operating Profit Margin
31.4%
EBITDA Margin
34.0%
Net Profit Margin
116.3%
FCF Margin
29.7%
Adj. FCF Margin
22.5%
SBC / Revenue
5.9%
SBC Impact (per share)
-24.2%

Returns

Return on Assets
61.8%
Return on Equity
96.5%
Return on Invested Capital
18.7%
Return on Capital Employed
20.4%
Return on Tangible Assets
75.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
29.8%
Revenue CAGR 5Y
13.9%
Revenue CAGR 10Y
22.9%
EPS CAGR 3Y
123.0%
EPS CAGR 5Y
180.9%
EPS CAGR 10Y
358.6%
FCF CAGR 3Y
105.1%
FCF CAGR 5Y
1131.3%
FCF CAGR 10Y
69.7%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
15
EPS Growth Next 3Y
-33.5%
Revenue Growth Next 3Y
21.6%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
$0.92
EPS Growth Est (next Q)
-36.9%
Revenue Est (next Q)
$80.1M
Revenue Growth Est (next Q)
15.3%

Fair Value Estimates

Graham Number
$91.82
Graham Upside
95.0%
Lynch Fair Value
$408
Lynch Upside
766.4%
Price Target
$67
Price Target Upside
42.3%

Cash Flow

Operating Cash Flow
$82.11M
Free Cash Flow
$82.11M
Adj. Free Cash Flow
$62.25M
FCF Per Share
$4.28
OCF Per Share
$4.28
OCF/S Ratio
28.7%

Income Statement

Revenue
$276.79M
Gross Profit
$252.95M
Operating Income
$87.05M
EBITDA
$93.18M
Net Income
$321.91M
EPS (Diluted)
$16.32
Revenue / Employee
$1.6M
Profit / Employee
$1.86M
Employees
173

© 2026 bestshares.com. All rights reserved.